News Image

CytoSorbents Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented at EuroPCR 2025

Provided By PR Newswire

Last update: May 22, 2025

Real-World Analysis Shows Statistically Significant Reduction in Severe Bleeding and Transfusion Needs in CABG Patients on the Blood Thinner, Ticagrelor, with CytoSorbents Therapy

Read more at prnewswire.com

CYTOSORBENTS CORP

NASDAQ:CTSO (12/9/2025, 4:30:00 PM)

0.749

+0.03 (+3.51%)



Find more stocks in the Stock Screener

Follow ChartMill for more